Infliximab Biosimilar for Intravenous Drip Infusion 100 mg "Pfizer" Drug Use Investigation (Rheumatoid Arthritis)
NCT03885037
·
clinicaltrials.gov ↗
COMPLETED
Status
77
Enrollment
INDUSTRY
Sponsor class
Conditions
Rheumatoid Arthritis
Interventions
DRUG:
Infliximab [infliximab biosimilar 3]
Sponsor
Pfizer